Your browser doesn't support javascript.
loading
The RGS2 (-391, C>G) genetic variation correlates to antihypertensive drug responses in Chinese patients with essential hypertension.
He, Fazhong; Luo, Jianquan; Zhang, Zhitao; Luo, Zhiying; Fan, Lan; He, Yijing; Wen, Jiagen; Zhu, Dingilang; Gao, Jinping; Wang, Yan; Qian, Yuesheng; Zhou, Honghao; Chen, Xiaoping; Zhang, Wei.
Afiliación
  • He F; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P.R.C; Institute of Clinical Pharmacology, Central South University, Changsha, P.R.C; Hunan Key Laboratory of Pharmacogenetics, Changsha, P.R.C.
  • Luo J; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P.R.C; Institute of Clinical Pharmacology, Central South University, Changsha, P.R.C; Hunan Key Laboratory of Pharmacogenetics, Changsha, P.R.C.
  • Zhang Z; Second uropoiesis surgical department in Han Dan Central Hospital, Handan, P.R.C.
  • Luo Z; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P.R.C; Institute of Clinical Pharmacology, Central South University, Changsha, P.R.C; Hunan Key Laboratory of Pharmacogenetics, Changsha, P.R.C.
  • Fan L; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P.R.C; Institute of Clinical Pharmacology, Central South University, Changsha, P.R.C; Hunan Key Laboratory of Pharmacogenetics, Changsha, P.R.C.
  • He Y; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P.R.C; Institute of Clinical Pharmacology, Central South University, Changsha, P.R.C; Hunan Key Laboratory of Pharmacogenetics, Changsha, P.R.C.
  • Wen J; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P.R.C; Institute of Clinical Pharmacology, Central South University, Changsha, P.R.C; Hunan Key Laboratory of Pharmacogenetics, Changsha, P.R.C.
  • Zhu D; Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, P.R.C.
  • Gao J; Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, P.R.C.
  • Wang Y; Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, P.R.C.
  • Qian Y; Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, P.R.C.
  • Zhou H; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P.R.C; Institute of Clinical Pharmacology, Central South University, Changsha, P.R.C; Hunan Key Laboratory of Pharmacogenetics, Changsha, P.R.C.
  • Chen X; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P.R.C; Institute of Clinical Pharmacology, Central South University, Changsha, P.R.C; Hunan Key Laboratory of Pharmacogenetics, Changsha, P.R.C.
  • Zhang W; Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, P.R.C; Institute of Clinical Pharmacology, Central South University, Changsha, P.R.C; Hunan Key Laboratory of Pharmacogenetics, Changsha, P.R.C.
PLoS One ; 10(4): e0121483, 2015.
Article en En | MEDLINE | ID: mdl-25849301

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Polimorfismo de Longitud del Fragmento de Restricción / Proteínas RGS / Hipertensión / Modelos Biológicos / Antihipertensivos Tipo de estudio: Guideline / Prognostic_studies País/Región como asunto: Asia Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2015 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Polimorfismo de Longitud del Fragmento de Restricción / Proteínas RGS / Hipertensión / Modelos Biológicos / Antihipertensivos Tipo de estudio: Guideline / Prognostic_studies País/Región como asunto: Asia Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2015 Tipo del documento: Article